HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: Preferential response to an HLA-G-derived nonamer

European Journal of Immunology

Volumn 28, Issue 9, 1998, Pages 2854-2863

  Llano, Manuel ^a   Lee, Ni ^b   Navarro, Francisco ^a   García, Pilar ^a   Albar, Juan Pablo ^c   Geraghty, Daniel E ^b   López Botet, Miguel ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b Fred Hutchinson Cancer Research Center   (United States)

^c CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

CD94; HLA E; HLA G; NK cell; Non classical MHC

Indexed keywords

CD94 ANTIGEN; HLA ANTIGEN CLASS 1; LYMPHOCYTE RECEPTOR; NONAPEPTIDE;

AMINO ACID SEQUENCE; ANTIGEN RECOGNITION; ARTICLE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL;

ANTIGENS, CD; ANTIGENS, CD94; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; PEPTIDES; SIGNAL TRANSDUCTION;

EID: 0031692643     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W     Document Type: Article

References (47)

1. Colonna, M. and Samaridis, J., Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995. 268: 405-408.
2. Wagtmann, N., Biassoni, R., Cantoni, C., Verdiani, S., Malnati, M. S., Vitale, M., Bottino, C., Moretta, L., Moretta, A. and Long, E. O., Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995. 2: 439-449.
3. Lanier, L. L., Natural killer cells: from no receptors to too many. Immunity 1997. 6: 371-378.
4. Moretta, A. and Moretta, L., HLA class I specific inhibitory receptors. Curr. Opin. Immunol. 1997. 9: 694-701.
5. Long, E. O. and Wagtmann, N., Natural killer cell receptors. Curr. Opin. Immunol. 1997. 9: 344-350.
6. Vivier, E. and Daëron, M., Immunoreceptor tyrosine-based inhibition motifs. Immunol. Today 1997. 18: 286-291.
7. Leibson, P. J., Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 1997. 6: 655-661.
8. Lanier, L. L., Corliss, B. C., Wu, J., Leong, C. and Phillips, J. H., Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 1998. 391: 703-707.
9. Olcese, L., Cambiaggi, A., Semenzato, G., Bottino, C., Moretta, A. and Vivier, E., Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J. Immunol. 1997. 158: 5083-5086.
10. Cosman, D., Fanger, N., Borges, L., Kubin, M., Chin, W., Peterson, L. and Hsu, M. L., A novel immunoglobulin super-family receptor for cellular and viral MHC class I molecules. Immunity 1997. 7: 273-282.
11. Colonna, M., Navarro, F., Bellón, T., Llano, M., García, P., Samaridis, J., Angman, L., Cella, M. and López-Botet, M., A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 1997. 186: 1809-1818.
12. Carretero, M., Cantoni, C., Bellón, T., Bottino, C., Biassoni, R., Rodríguez, A., Pérez-Villar, J. J., Moretta, L., Moretta, A. and López-Botet, M., The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 1997. 27: 563-567.
13. López-Botet, M., Carretero, M., Bellón, T., Pérez-Villar, J. J., Llano, M. and Navarro, F., The CD94/NKG2 C-type lectin receptor complex. Curr. Top. Microbiol. Immunol. 1998. 230: 41-52.
14. Lazetic, S., Chang, C., Houchins, J. P., Lanier, L. L. and Phillips, J. H., Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 1996. 157: 4741-4745.
15. Pérez-Villar, J. J., Melero, I., Rodríguez, A., Carretero, M., Aramburu, J., Sivori, S., Orengo, A. M., Moretta, A. and López-Botet, M., Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J. Immunol. 1995. 154: 5779-5788.
16. Pérez-Villar, J. J., Carretero, M., Navarro, F., Melero, I., Rodriguez, A., Bottino, C., Moretta, A. and López-Botet, M., Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor. J. Immunol. 1996. 157: 5367-5374.
17. Houchins, J. P., Lanier, L. L., Niemi, E. C., Phillips, J. H. and Ryan, J. C., Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J. Immunol. 1997. 158: 3603-3609.
18. Cantoni, C., Biassoni, R., Pende, D., Sivori, S., Accame, L., Pareti, L., Semenzato, G., Moretta, L., Moretta, A. and Bottino, C., The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. Eur. J. Immunol. 1998. 28: 327-338.
19. Phillips, J. H., Chang, C., Mattson, J., Gumperz, J. E., Parham, P. and Lanier, L. L., CD94 and a novel associated protein (94AP) from a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity 1996. 5: 163-172.
20. Sivori, S., Vitale, M., Bottino, C., Marcenaro, E., Sanseverino, L., Parolini, S., Moretta, L. and Moretta, A., CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur. J. Immunol. 1996. 26: 2487-2492.
21. Braud, V. M., Allan, D. S., O'Callaghan, C. A., Soderstrom, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., Lanier, L. L. and McMichael, A. J., HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998. 391: 795-799.
22. Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E. and Brooks, A. G., Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/ NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 1998. 187: 813-818.
23. Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M. and Geraghty, D., HLA-E is a major ligand for the natural killer inhibitory receptor CD94/ NKG2A. Proc. Natl. Acad. Sci. USA 1998. 95: 5199-5204.
24. Carretero, M., Palmieri, G., Llano, M., Tullio, V., Santoni, A., Geraghty, D. E. and López-Botet, M., Specific engagement of the CD94/NKG2A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2A: evidence for receptor function in heterologous transfectants. Eur. J. Immunol. 1998. 28: 1280-1291.
25. Lee, N., Goodlett, D. R., Ishitani, A., Marquardt, H. and Geraghty, D. E., HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 1998. 160: 4951-4960.
26. Braud, V., Jones, E. Y. and McMichael, A., The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur. J. Immunol. 1997. 27: 1164-1169.
27. O'Callaghan, C. A., Tormo, J., Willcox, B. E., Braud, V., Jakobsen, B. K., Stuart, D. I., McMichael, A. and Green, D. R., Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Mol. Cell 1998. 1: 531-541.
28. Bunce, M., Barnardo, M. C., Procter, J., Marsh, S. G., Vilches, C. and Welsh, K. I., High resolution HLA-C typing by PCR-SSP: identification of allelic frequencies and linkage disequilibria in 604 unrelated random UK Caucasoids and a comparison with serology. Tissue Antigens 1996. 48: 680-691.
29. Biassoni, R., Pessino, A., Malaspina, A., Cantoni, C., Bottino, C., Sivori, S., Moretta, L. and Moretta, A., Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur. J. Immunol. 1997. 27: 3095-3099.
30. Carosella, E. D., Dausset, J. and Kirszenbaum, M., HLA-G revisited. Immunol. Today 1996. 17: 407-409.
31. King, A., Hiby, S. E., Verma, S., Burrows, T., Gardner, L. and Loke, Y. W., Uterine NK cells and trophoblast HLA class I molecules. Am J. Reprod. Immunol. 1997. 37: 459-462.
32. Damsky, C., Fitzgerald, M. and Fisher, S., Distribution patterns of extracellular matrix components and adhesion receptors are intrinsically modulated during first trimester cytotrophoblast differentiation along the invasive pathway in vivo. J. Clin. Invest 1992. 89: 210-222.
33. Clover, L. M., Sargent, I. L., Townsend, A., Tampe, R. and Redman, C. W., Expression of TAP1 by human trophoblast. Eur. J. Immunol. 1995. 25: 543-553.
34. Roby, K. F., Gershon, D. and Hunt, J. S., Expression of the transporter for antigen processing-1 (TAP-1) gene in subpopulations of human trophoblast cells. Placenta 1996. 17: 27-32.
35. Fisher, S. J. and Damsky, C. H., Human cytotrophoblast invasion. Semin. Cell Biol. 1993. 4: 183-188.
36. Schust, D. J., Hill, A. B. and Ploegh, H. L., Herpes Simplex virus blocks intracellular transport of HLA-G in placentally derived human cells. J. Immunol. 1996. 157: 3375-3380.
37. Robb, J., Benirshje, K. and Barmeyer, R., Intrauterine latent herpes simplex virus infection: spontaneous abortion. Hum. Pathol. 1986. 17: 1196-1199.
38. Soderström, K., Corliss, B., Lanier, L. L. and Phillips, J. H., D94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. J. Immunol. 1997. 159: 1072-1075.
39. Pende, D., Sivori, S., Accame, L., Pareti, L., Falco, M., Geraghty, D., Le Bouteiller, P., Moretta, L. and Moretta, A., HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. Eur. J. Immunol. 1997. 27: 1875-1880.
40. Pérez-Villar, J. J., Melero, I., Navarro, F., Carretero, M., Bellón, T., Llano, M., Colonna, M., Geragthy, D. E. and López-Botet, M., The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J. Immunol. 1997. 158: 5736-5743.
41. Pazmany, L., Mandelboim, O., Valés-Gómez, M., Davis, D. M., Reyburn, H. T. and Strominger, J. L., Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 1996. 274: 792-795.
42. Munz, C., Holmes, N., King, A., Loke, Y. W., Colonna, M., Schild, H. and Rammensee, H. G., Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J. Exp. Med. 1997. 185: 385-391.
43. Mandelboim, O., Pazmany, L., Davis, D. M., Valés-Gómez, M., Reyburn, H. T., Rybalov, B. and Strominger, J. L., Multiple receptors for HLA-G on human natural killer cells. Proc. Natl. Acad. Sci. USA 1997. 94: 14666-14670.
44. Aramburu, J., Balboa, M. A., Ramírez, A., Silva, A., Acevedo, A., Sánchez-Madrid, F., De Landazuri, M. O. and López-Botet, M., A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody. J. Immunol. 1990. 144: 3238-3247.
45. Melero, I., Salmerón, A., Balboa, M. A., Aramburu, J. and López-Botet, M., Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes. J. Immunol. 1994. 152: 1662-1673.
46. Robertson, M. J-, Cochran, K. J., Cameron, C., Le, J. M., Tantravahi, R. and Ritz, J., Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. 1996. 24: 406-415.
47. Gausepohl, H., Boulin, C., Kraft, M. and Frank, R. W., Automated multiple peptide synthesis. Pept. Res. 1992. 5: 315-320.